Pulmonary Hypertension (PH) is a complex and progressive disease characterized by elevated pulmonary arterial pressure. It is critical for healthcare professionals to understand its pathophysiology, diagnosis, and treatment options.
PH is associated with a variety of conditions and factors, including heart diseases, connective tissue disorders, and lung diseases. The primary pathophysiological change is the narrowing or blockage of pulmonary arteries, leading to increased resistance and pressure in these vessels.
Diagnosing PH can be challenging due to its nonspecific symptoms, such as shortness of breath, fatigue, and chest pain. The gold standard for diagnosis is right heart catheterization, which provides direct measurement of pulmonary arterial pressure. Other diagnostic tools include echocardiography, pulmonary function tests, and imaging studies like CT and MRI.
While PH is incurable, treatments aim to control symptoms and slow disease progression. Therapeutic strategies include vasodilator drugs, anticoagulants, diuretics, and oxygen therapy. In severe cases, lung transplantation may be considered.
Medical professionals play a crucial role in managing PH. Early diagnosis and initiation of appropriate treatment are critical to improving patient outcomes. Furthermore, patient education about disease management and lifestyle modifications can significantly enhance their quality of life.
Understanding the fundamentals of PH is essential for optimal patient care. As healthcare professionals, we must stay abreast with the latest research and advancements in this field to provide the best possible care to our patients.
1.
Prostate cancer detection with PET CT and PET MRI is comparable.
2.
Refractory Multiple Myeloma Responsive to Immunotherapy Plus Low-Dose Radiotherapy
3.
AI Breath Test IDs Cancers; More Grief for Prior Auth; Imatinib Discoverer Resigns
4.
In NSCLC, subcutaneous Lazertinib + Amivantamab Dosing Is Not Worse Than IV Dosing.
5.
Loncastuximab-Rituximab Boosts Response Rates in R/R Follicular Lymphoma
1.
Innovative Intraoperative Therapies in Neurosurgical Oncology: Advancing Precision and Outcomes
2.
Unlocking the Potential of Bicalutamide 50 mg: A Revolutionary New Treatment for Prostate Cancer
3.
Holistic Oncology: Advancing Survivorship, Nursing, and Innovative Cancer Care Models
4.
Emerging Chemo-Immunotherapy: New Agents and Mechanisms in Modern Oncology
5.
The Dangers of Supratherapeutic INR: The Need for Increased Awareness and Monitoring
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Thromboprophylaxis In Medical Settings
2.
EGFR Mutation Positive Non-Small Cell Lung Cancer- Case Discussion & Conclusion
3.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC
4.
Efficient Management of First line ALK-rearranged NSCLC
5.
Post Progression Approaches After First-line Third-Generaion ALK Inhibitors
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation